What You Should Know:
- Hepta, a biotechnology company focused on diagnosing chronic disease, has emerged from stealth announcing $6.7M in seed funding co-led by Felicis Ventures and Illumina Ventures, with participation from SeaX Ventures, Alumni Ventures, and AME Cloud Ventures.
- The company's core technology utilizes transformer-based AI to read the cell-free DNA (cfDNA) epigenome, enabling the detection of organ-specific signals for chronic conditions. Built by former leaders from
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Healthcare Consumer Experience 2025: Safety, AI, and Social Capital Redefine Trust
What You Should Know:
- Press Ganey, the leader in experience measurement, analytics, and advisory services for health systems and health plans, today released its extensive report, Healthcare consumer experience 2025.
- The report explores new data on how people make healthcare decisions in an era where patients are empowered consumers who expect clarity, convenience, and compassion in every interaction—digital or human. To keep pace, the industry must approach consumer
Read More
PocketHealth Launches Conductor Agentic AI System to Automate Every Non-Clinical Step of Care
What You Should Know:
- PocketHealth today announced the launch of Conductor, an agentic AI system built to automate every non-clinical step of care, from requisition intake and order creation to scheduling and appointment confirmations.
- The solution is directly aimed at helping healthcare systems across North America manage rising patient volumes, shrinking staff resources, and growing administrative costs.
I. Orchestrating Workflows to End the Administrative
Read More
Onchilles Pharma Raises $25M to Advance N17350, Pioneering Next-Gen Cytotoxic Cancer Therapy
What You Should Know:
- Onchilles Pharma, a private biotech company pioneering next-generation cytotoxic therapeutics announced the publication of foundational preclinical data in the peer-reviewed journal Cell Reports Medicine, the close of a $25M Series A1 financing round.
- In addition, the company appointed Dr. Thomas A. Buchholz as a clinical advisor. The funding brings the total raised in Series A financing to $40M.
Foundational Preclinical Data Validates Cancer-Selective
Read More
UHN and Helix Launch Canada’s Largest Population Genomics Initiative
What You Should Know:
- University Health Network's (UHN's) Princess Margaret Cancer Centre and Helix, a precision health organization, today announced a landmark partnership to launch one of the largest population genomics studies in Canada.
- The initiative, known as the OurGenes Study, aims to enroll up to 100,000 participants over five years, advancing precision medicine and the early detection of hereditary health risks.
Targeting Actionable Hereditary Health Risks
The
Read More
Trump Unveils Historic Drug Price Cuts: Ozempic and Wegovy Reduced to $350 via TrumpRx
What You Should Know:
- President Donald J. Trump announced the latest in a series of significant actions to lower prescription drug prices, unveiling agreements with pharmaceutical manufacturers Eli Lilly and Company and Novo Nordisk.
- The initiative delivers historic price reductions on some of the world’s most popular drugs, impacting millions of Americans struggling with chronic diseases, diabetes, heart disease, and obesity.
Price Reductions for Patients and
Read More
Amae Health Secures $25M to Transform Severe Mental Illness Care with Integrated AI Platform
What You Should Know:
- Amae Health, a Public Benefit Corporation (PBC) and leader in outpatient treatment for Severe Mental Illness (SMI), announced the close of a $25M of pre-empted Series B financing led by Altos Ventures.
- The funding brings Amae’s total funding to more than $50M and will accelerate the company's mission to transform how conditions like schizophrenia, bipolar disorder, and treatment-resistant depression are understood and treated.
Achieving Significant and
Read More
Rise of Deepfake HR Scams: How GenAI is Fueling the New Era of Applicant Fraud in Healthcare
Every HR and talent acquisition (TA) professional has experienced a bad hire. You carefully review and assess a candidate’s skills, experience, and credentials. You evaluate them through a series of interviews with multiple stakeholders. You’re all but certain they’ll be a perfect fit for the role. And, then, three weeks into their tenure you realize you’ve made a huge mistake.
The occasional bad hire is all but inevitable. But now, HR and TA professionals have something much more
Read More
American Red Cross Launches Resuscitation Suite App to Transform Lifesaving Care
What You Should Know:
- The American Red Cross, a trusted leader in lifesaving training, announced the addition of a new mobile app to its Resuscitation Suite™ programs.
- The Resuscitation Suite App, powered by Redivus Health, is designed to support and enhance training across the entire resuscitation portfolio, including Basic Life Support (BLS), Advanced Life Support (ALS), Pediatric Advanced Life Support (PALS), and Neonatal Advanced Life Support (NALS).
Evidence-Based
Read More
Weave Bio Launches HAQ Manager: AI Automation Accelerates Health Authority Question Responses
What You Should Know:
- Weave Bio, the leader in AI-native regulatory automation, today announced the launch of HAQ Manager, a breakthrough capability that applies artificial intelligence (AI) and workflow automation to accelerate responses to Health Authority Questions (HAQs) during regulatory review.
- This launch extends Weave's platform beyond submission preparation into the critical post-submission review phase, helping organizations navigate one of the most time-pressured and
Read More
